MDS or MPN?
Myelodysplastic syndromes or myeloproliferative Neoplasms? These diseases may sound similar and share similar characteristics, but it's important to understand what makes them different. Dr. Brandi Reeves joins us in this HealthTree for MDS educational webinar to walk us through this topic.
Mary introduces the agenda for the event and featured speaker Dr. Brandi Reeves
Dr. Reeves will present on what MPN's are and what differentiates them from MDS.
Type your questions in the chat and Dr. Reeves will answer them!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Brandi Reeves
Dr. Brandi Reeves is a physician-scientist specializing in myeloproliferative neoplasms (MPN), bone marrow failure syndromes, lower risk myelodysplastic syndromes (MDS), and clonal hematopoiesis. I lead our MPN program, which was established in 2019 and provides clinical and research expertise for MPN patients. Her research primarily focuses on mechanisms of thrombosis in MPN, with a goal to improve MPN care by individualizing thrombosis risk stratification and by finding better treatments to prevent thrombosis. She is also dedicated to training the next generation of physicians and am involved in medical student, resident, and fellow education.